Global Amino Acid Metabolism Disorders Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Amino Acid Metabolism Disorders Treatment Market is presumed to reach the market size of nearly USD 1101.11 Million by 2032 from USD 715.29 Million in 2023 with a CAGR of 4.91% under the study period 2024-2032.

Amino acid metabolism disorders are inherited metabolic diseases that usually manifest in childhood. These disorders affect the metabolism of amino acids such as phenylketonuria, tyrosinemia, homocystinuria, and non-ketotic hyperglycinemia among others. These disorders are autosomal recessive, and can be diagnosed by analyzing amino acid concentrations in body fluids. Amino acid metabolism disorders treatments may include special diets, medicines, and few supplements. Blood tests, dialysis and transplants are some of the amino acid metabolism disorders treatment.

MARKET DYNAMICS

In the future, the global amino acid metabolism disorders treatment market is predicted to rise due to the rising prevalence of amino acid metabolism disorders such as phenylketonuria and maple syrup urine. The expansion of the amino acid metabolism disorder therapy market would be slowed in the forthcoming years due to rising costs of amino acid supplements and patient non-compliance. Familial hypercholesterolemia, Gaucher disease, Hunter syndrome, Krabbe disease, Metachromatic leukodystrophy, Mitochondrial encephalopathy, lactic acidosis, stroke-like episodes (MELAS), and Niemann-Pick disease are expected to be significant growth drivers for the amino acid metabolism disorders treatment market over the forecast period. Again, the rising prevalence of chronic diseases necessitates more effective treatment management to enhance patient outcomes. As a result, the amino acid metabolism disorders therapy market is expected to increase significantly throughout the forecast period.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Amino Acid Metabolism Disorders Treatment. The growth and trends of Amino Acid Metabolism Disorders Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Amino Acid Metabolism Disorders Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Indication

Argininosuccinic Academia
Citrullinemia
Homocystinuria
Phenylketonuria
Maple Syrup Urine Disease

By Product

Arginine
Betaine
Carglumic Acid
Folic Acid
Sapropterin Dihydrochloride
Thiamine
Vitamin B6 and B12
Vitamin D

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Stores

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Amino Acid Metabolism Disorders Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Amino Acid Metabolism Disorders Treatment market include Amino GmbH, Civentichem LLC, Koninklijke DSM N.V., Kyowa Hakko Kirin Co. Ltd, Merck KGaA And Recordati S.P.A. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11218237

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. AMINO ACID METABOLISM DISORDERS TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Indication
- 3.7.2 Market Attractiveness Analysis By Product
- 3.7.3 Market Attractiveness Analysis By Distribution Channel
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET ANALYSIS BY INDICATION

5.1. Overview By Indication
5.2. Historical and Forecast Data Analysis By Indication
5.3. Argininosuccinic Academia Historic and Forecast Sales By Regions
5.4. Citrullinemia Historic and Forecast Sales By Regions
5.5. Homocystinuria Historic and Forecast Sales By Regions
5.6. Phenylketonuria Historic and Forecast Sales By Regions
5.7. Maple Syrup Urine Disease Historic and Forecast Sales By Regions

6. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET ANALYSIS BY PRODUCT

6.1. Overview By Product
6.2. Historical and Forecast Data Analysis By Product
6.3. Arginine Historic and Forecast Sales By Regions
6.4. Betaine Historic and Forecast Sales By Regions
6.5. Carglumic Acid Historic and Forecast Sales By Regions
6.6. Folic Acid Historic and Forecast Sales By Regions
6.7. Sapropterin Dihydrochloride Historic and Forecast Sales By Regions
6.8. Thiamine Historic and Forecast Sales By Regions
6.9. Vitamin B6 and B12 Historic and Forecast Sales By Regions
6.10. Vitamin D Historic and Forecast Sales By Regions

7. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

7.1. Overview By Distribution Channel
7.2. Historical and Forecast Data Analysis By Distribution Channel
7.3. Hospital Pharmacies Historic and Forecast Sales By Regions
7.4. Retail Pharmacies Historic and Forecast Sales By Regions
7.5. Online Stores Historic and Forecast Sales By Regions

8. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE AMINO ACID METABOLISM DISORDERS TREATMENT COMPANIES

9.1. Amino Acid Metabolism Disorders Treatment Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF AMINO ACID METABOLISM DISORDERS TREATMENT INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Amino GmbH
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Civentichem LLC
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Koninklijke DSM N.V.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Kyowa Hakko Kirin Co. Ltd
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Merck KGaA And Recordati S.P.A
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies